Serum neurofilament heavy chains as a biomarker of neuronal damage in multiple sclerosis relapse
Introduction. One of the newest methods that could facilitate the diagnosis and treatment of multiple sclerosis is the measurement of neurofilament levels in the blood and spinal fluid. Neurofilament chains can be found not only in multiple sclerosis but also in other neurodegenerative diseases. La...
Saved in:
| Main Authors: | P. Beliaziūnas, R. Godelienė, L. Malcienė, V. Natkevičius, V. Gintauskienė, B. Šitkauskienė, M. Malciūtė |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Vilnius University Press
2021-03-01
|
| Series: | Neurologijos seminarai |
| Subjects: | |
| Online Access: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/27704 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of neurofilament light chain in the context of neurological disorders
by: V. Taluntienė, et al.
Published: (2020-12-01) -
Neurodegenerative Biomarkers in Multiple Sclerosis: At the Interface Between Research and Clinical Practice
by: Alin Ciubotaru, et al.
Published: (2025-05-01) -
The Association of Axonal Damage Biomarkers and Osteopontin at Diagnosis Could Be Useful in Newly Diagnosed MS Patients
by: Eleonora Virgilio, et al.
Published: (2025-07-01) -
Neurofilament light chain in the assessment of patients with multiple sclerosis
by: Renan Barros DOMINGUES, et al. -
The relation between serum neurofilament light chain levels and disease severity in multiple sclerosis: insights from an Egyptian study
by: Hagar S. Ali, et al.
Published: (2025-07-01)